+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

India Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Parenteral, Topical, Others), By Form, By Source, By Distribution Channel, By Application, By Region, Competition, Forecast & Opportunities, 2018-2028F

  • PDF Icon

    Report

  • 73 Pages
  • July 2022
  • Region: India
  • TechSci Research
  • ID: 5624618
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Indian Generic Drugs Market stood at USD 24.53 Billion in 2022 and is expected to grow at a steady CAGR of 6.97% during the forecast period.



The growing prevalence of chronic diseases such as diabetes, cardiovascular disease, etc., and sedentary lifestyle propel market growth. The expanding geriatric population is contributing to the market growth as the comorbidities are more in the old population, thereby needing proper medications with the easiest route for drug administration. In developing countries like India, government bodies and other regulatory bodies have encouraged manufacturers to launch effective generic drugs supporting market growth. The introduction of 3-D printing technology helps in manufacturing generic drugs with varying release dates and tastes and is expected to propel market growth.

The short expiration and gap between re-filing of the new drug encourages various companies to produce generic drugs owing to rise in competition which further reduces the generic medication prices. Enhancing accessibility to healthcare services and growing healthcare awareness among the public drive market growth. Several initiatives are undertaken by government bodies towards awareness of the availability of generics like Pradhan Mantri Bhartiya and Jan Aushadi Yojana have become the highlight, offering quality medicines at affordable prices to the people. This scheme is currently running in each state of India with its high popularity among the people with average to low-income categories providing the public access to medications.

The Indian Generic Drugs Market is segmented based on type, mode of drug delivery, form, source, distribution channel, application, and region. Based on type, the market can be split into small molecule generics and biosimilars. Small molecule generic drugs held the largest market share of 70.01% in 2022. This is due to the low cost of generic drugs compared to branded drugs and affordability to the large segment of patients from middle to low-income families.

The significant market players operating in the Indian Generic Drugs Market include Sun Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited., Cipla Limited, Lupin Limited, Piramal Group, Glenmark Pharmaceuticals Limited, Biocon Limited, Dr. Reddy’s Laboratories Limited, Aurobindo Pharma Limited.

Years considered for this report:

Historical Years: 2018-2021
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2024-2028

Objective of the Study:

  • To analyze the historical growth of the market size of the Indian Generic Drugs Market from 2018 to 2021.
  • To estimate and forecast the market size of the Indian Generic Drugs Market from 2023 to 2028 and growth rate until 2028.
  • To classify and forecast the Indian Generic Drugs Market based on type, mode of drug delivery, form, source, distribution channel, application, regional distribution, and competitive landscape.
  • To identify dominant region or segment in the Indian Generic Drugs Market.
  • To identify drivers and challenges for the Indian Generic Drugs Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Indian Generic Drugs Market.
  • To identify and analyze the profile of leading players operating in the Indian Generic Drugs Market.
  • To identify key sustainable strategies adopted by the market players in the Indian Generic Drugs Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of generic drugs manufacturing companies across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the vendors which could not be identified due to the limitations of secondary research.

The publisher calculated the Indian Generic Drugs Market size by using a bottom-up approach, where data for various end-user industries and its application across various product types were recorded and forecast for the future years. The publisher Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by the publisher.

Key Target Audience:

  • Generic drugs manufacturing companies/partners
  • End-users
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to generic drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as generic drugs manufacturing companies, end-users etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:


In this report, the Indian Generic Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

India Generic Drugs Market, By Type:

  • Small Molecule Generics
  • Biosimilars

India Generic Drugs Market, By Mode of Drug Delivery:

  • Oral
  • Topical
  • Parenteral
  • Others

India Generic Drugs Market, By Form:

  • Tablets
  • Capsule
  • Injection
  • Others

India Generic Drugs Market, By Source:

  • Contract Manufacturing Organizations
  • In- House

India Generic Drugs Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

India Generic Drugs Market, By Application:

  • Neurology
  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Anti-Inflammatory
  • Others

India Generic Drugs Market, By Region:

  • North
  • South
  • West
  • East


Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Indian Generic Drugs Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Frequently Asked Questions about the Indian Generic Drugs Market

What is the estimated value of the Indian Generic Drugs Market?

The Indian Generic Drugs Market was estimated to be valued at $20.79 Billion in 2018.

What is the growth rate of the Indian Generic Drugs Market?

The growth rate of the Indian Generic Drugs Market is 5.7%, with an estimated value of $36.51 Billion by 2028.

What is the forecasted size of the Indian Generic Drugs Market?

The Indian Generic Drugs Market is estimated to be worth $36.51 Billion by 2028.

Who are the key companies in the Indian Generic Drugs Market?

Key companies in the Indian Generic Drugs Market include Sun Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Piramal Group, Glenmark Pharmaceuticals Limited, Biocon Limited, Dr. Reddy's Laboratories Limited and Teva Pharmaceuticals Limited.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on India Generic Drugs Market4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness
5.2. Preference, By Mode of Purchase
5.3. Demand, By Therapeutic Area
5.4. Sources of Information
6. India Generic Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Small Molecule Generics v/s Biosimilars)
6.2.2. By Mode of Drug Delivery (Oral, Parenteral, Topical, Others)
6.2.3. By Form (Tablets, Capsules, Injections, Others)
6.2.4. By Source (Contract Manufacturing Organizations v/s In-House Manufacturing)
6.2.5. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others)
6.2.6. By Application (Cardiovascular Diseases, Diabetes, Oncology, Neurology, Anti-Inflammatory Diseases, Others)
6.2.7. By Region
6.2.7.1. By States (Top 3 States)
6.2.8. By Company (2022)
6.3. Product Market Map
7. India Small Molecule Generic Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Mode of Drug Delivery
7.2.2. By Form
7.2.3. By Source
7.2.4. By Distribution Channel
7.2.5. By Application
8. India Biosimilar Generic Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Mode of Drug Delivery
8.2.2. By Form
8.2.3. By Source
8.2.4. By Distribution Channel
8.2.5. By Application
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments11. Policy & Regulatory Landscape12. India Economic Profile
13. Competitive Landscape
13.1. Competition Outlook
13.2. Company Profiles
13.2.1. Sun Pharmaceutical Industries Limited
13.2.2. Torrent Pharmaceuticals Limited
13.2.3. Cipla Limited
13.2.4. Lupin Limited
13.2.5. Piramal Group
13.2.6. Glenmark Pharmaceuticals Limited
13.2.7. Biocon Limited
13.2.8. Dr. Reddy's Laboratories Limited
13.2.9. Aurobindo Pharma Limited
13.2.10. Teva Pharmaceuticals Limited
14. Strategic Recommendations
(Note: The companies list can be customized based on the client requirements.)
Notes: The data given for any year represents the market during the period, i.e., 1st April of the previous year to 31st March of that year. eg: For 2023E, the data represents the period, 1st April 2022 to 31st March 2023.
List of Figures
Figure 1: India Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 2: India Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 3: India Generic Drugs Market Share, By Mode of Drug Delivery, By Value, 2018-2028F
Figure 4: India Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 5: India Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 6: India Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 7: India Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 8: India Generic Drugs Market Share, By Region, By Value, 2018-2028F
Figure 9: South India Generic Drugs Market Share, By State, By Value, 2018-2028F
Figure 10: North India Generic Drugs Market Share, By State, By Value, 2018-2028F
Figure 11: West India Generic Drugs Market Share, By State, By Value, 2018-2028F
Figure 12: East India Generic Drugs Market Share, By State, By Value, 2018-2028F
Figure 13: India Generic Drugs Market Share, By Company, By Value, 2022
Figure 14: India Generic Drugs Market Map, By Type, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 15: India Generic Drugs Market Map, By Mode of Drug Delivery, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 16: India Generic Drugs Market Map, By Form, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 17: India Generic Drugs Market Map, By Source, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 18: India Generic Drugs Market Map, By Distribution Channel, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 19: India Generic Drugs Market Map, By Application, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 20: India Generic Drugs Market Map, By Region, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 21: India Small Molecule Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 22: India Small Molecule Generic Drugs Market Share, By Mode of Drug Delivery, By Value, 2018-2028F
Figure 23: India Small Molecule Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 24: India Small Molecule Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 25: India Small Molecule Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 26: India Small Molecule Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 27: India Biosimilar Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 28: India Biosimilar Generic Drugs Market Share, By Mode of Drug Delivery, By Value, 2018-2028F
Figure 29: India Biosimilar Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 30: India Biosimilar Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 31: India Biosimilar Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 32: India Biosimilar Generic Drugs Market Share, By Application, By Value, 2018-2028F

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Sun Pharmaceutical Industries Limited
  • Torrent Pharmaceuticals Limited
  • Cipla Limited
  • Lupin Limited
  • Piramal Group
  • Glenmark Pharmaceuticals Limited
  • Biocon Limited
  • Dr. Reddy's Laboratories Limited
  • Aurobindo Pharma Limited
  • Teva Pharmaceuticals Limited